💊 Drugs • 11,927 recalls
Auro Pharmacies
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Auro Pharmacies
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Westminster Pharmaceuticals
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Jubilant Cadista Pharmaceuticals
Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.
Westminster Pharmaceuticals
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Westminster Pharmaceuticals
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
A-S Medication Solutions
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Failed Impurities/Degradation Specifications; out of specification results for related compound per the manufacturer
A-S Medication Solutions
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Jubilant Cadista Pharmaceuticals
Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
A-S Medication Solutions
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Jubilant Cadista Pharmaceuticals
Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.
Preferred Pharmaceuticals
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Jubilant Cadista Pharmaceuticals
Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.
A-S Medication Solutions
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Westminster Pharmaceuticals
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.